Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07070401 · ClinicalTrials.gov registry record · NA
The Use of AR / VR in Patients Presenting to the ED With Renal Colic
A NA study of Renal Colic and Kidney Stones, Urolithiasis, Hypocitraturia, sponsored by Community Medical Center, Toms River, NJ.
- Recruiting
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT07070401: Recruiting NA study of Renal Colic and Kidney Stones, Urolithiasis, Hypocitraturia, sponsored by Community Medical Center, Toms River, NJ.
NCT07070401 is a NA study of Renal Colic and Kidney Stones, Urolithiasis, Hypocitraturia that is actively recruiting participants, run by Community Medical Center, Toms River, NJ. The registered enrollment target is 92 participants, above the 69-participant average among 3 other Renal Colic trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07070401, a NA study of Renal Colic and Kidney Stones, Urolithiasis, Hypocitraturia, is actively recruiting participants, sponsored by Community Medical Center, Toms River, NJ.
- RECRUITING
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
Utilization of VR / AR Calming as an adjunct to pharmacologic pain management for Renal Colic in Emergency Department Patients
Primary Outcome
Pain Level Change 60 minutes after enrollment, utilizing a 0-10 subjective score
Conditions Studied
Interventions
- DEVICE Commercial AR/VR Headset with Calming App
- OTHER Pharmacologic Standard of Care Alone
Study Locations (1)
New Jersey
- Rutgers Robert Wood Johnson Barnabas Health Community Medical Center - Toms River
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2025-04-01 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
What NCT07070401 shows while recruiting
NCT07070401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, above the 69-participant average among 3 other Renal Colic trials with a reported enrollment target (33% higher).
The record links to 2 conditions, with Renal Colic appearing as the primary indexed condition, and to 2 interventions - of which Commercial AR/VR Headset with Calming App is the first listed.
NCT07070401 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07070401 about?
NCT07070401 is a clinical study titled "The Use of AR / VR in Patients Presenting to the ED With Renal Colic". Utilization of VR / AR Calming as an adjunct to pharmacologic pain management for Renal Colic in Emergency Department Patients
What is the current status of trial NCT07070401?
This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2025-04-01. Estimated completion is 2026-03-31.
What conditions does trial NCT07070401 study?
This clinical trial studies the following conditions: Renal Colic, Kidney Stones, Urolithiasis, Hypocitraturia.
What interventions are being tested in trial NCT07070401?
The interventions under investigation include: Commercial AR/VR Headset with Calming App (DEVICE), Pharmacologic Standard of Care Alone (OTHER).
Who is sponsoring clinical trial NCT07070401?
This trial is sponsored by Community Medical Center, Toms River, NJ, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07070401 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Colic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
RECRUITING · Phase 4
-
Erector Spinae Plane (ESP) Block for Renal Colic
ACTIVE NOT RECRUITING · Phase 4
-
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI